Check out the main topics of the upcoming SOLACI-CACI 2021 Congress. Save the Date!
Special Session About the COVID-19 Pandemic
Managing Cardiovascular disease and Cath Lab during the COVID-19 Pandemic
Live Case Transmissions
Coronary and Structural cases performed by distinguished international and national operators.
Coronary Track
Myocardial Infarction, Left Main session, Complex Bifurcations, CTO, Diffuse disease, small vessels and more.
DES latest improvements and designs, Drug eluting balloons, ablation.
Results of Revascularization Strategies in Major Randomized clinical trials: Myths and Realities.
Antiplatelet and Pharmacologic approaches during and after PCI: Lessons learned from Randomized trials and registries.
Structural Track
TAVI Techniques, Designs, Results and Indication in low , intermediate and high risk patients.
Mitral Valve Repair and Replacement When and How.
Tricuspid Valve Repair and Replacement: When and How.
PFO and left appendage closure: When and How.
International Joint Sessions
*Partnership Session with major Interventional Cardiology Societies from USA, Europe and Asia: TCT, PCR, SCAI, C3, International Andreas Gruentzig Society, CBS, Indian Life and more.
ProEducar Fellows Course for Interventionists in Training
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....
We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....